REQUEST A DEMO
Total
USD $0.00
Search more companies

Scirent Clinical Research And Science D.O.O. (Serbia)

Main Activities: Research and Development in Nanotechnology
Full name: Scirent Clinical Research And Science D.O.O. Profile Updated: October 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Scirent Clinical Research And Science D.O.O. is an enterprise in Serbia, with the main office in Belgrade. The enterprise operates in the Research and Development in Nanotechnology industry. Scirent Clinical Research And Science D.O.O. was incorporated on January 13, 2026. Scirent Clinical Research And Science D.O.O. currently employs 24 (2023) people.

Headquarters
Dedinjska 5
Belgrade; Belgrade;

Contact Details: Purchase the Scirent Clinical Research And Science D.O.O. report to view the information.

Basic Information
Total Employees:
Purchase the Scirent Clinical Research And Science D.O.O. report to view the information.
Registered Capital:
Purchase the Scirent Clinical Research And Science D.O.O. report to view the information.
Financial Auditors:
Purchase the Scirent Clinical Research And Science D.O.O. report to view the information.
Incorporation Date:
January 13, 2026
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
47%
Purchase this report to view the information.
47%
Purchase this report to view the information.
6%
Company Performance
Financial values in the chart are available after Scirent Clinical Research And Science D.O.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Total operating revenue
-10.36%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?